BSX
Boston Scientific Corporation
Stock
$42.60−0.63 (−1.46%)Close Oct 2, 2026
- Shareholders' equity, 2025
- $24.2B
- YoY, 2025
- +11.3%
- 5-year CAGR
- +9.6%
- 10-year CAGR
- +14.4%
Shareholders' equity
Shareholders' equity by fiscal year
| Period | Equity | YoY |
|---|---|---|
| 2025 | $24.2B | +11.3% |
| 2024 | $21.8B | +12.9% |
| 2023 | $19.3B | +9.7% |
| 2022 | $17.6B | +5.7% |
| 2021 | $16.6B | +8.5% |
| 2020 | $15.3B | +10.4% |
| 2019 | $13.9B | +59.0% |
| 2018 | $8.7B | +24.4% |
| 2017 | $7.0B | +4.1% |
| 2016 | $6.7B | +6.5% |
| 2015 | $6.3B | −2.1% |
| 2014 | $6.5B | −1.3% |
| 2013 | $6.5B | −4.8% |
| 2012 | $6.9B | −39.5% |
| 2011 | $11.4B | +0.5% |
| 2010 | $11.3B | −8.2% |
| 2009 | $12.3B | −6.6% |
| 2008 | $13.2B | — |